Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 839 | Longs Won 440/834 52% | Profit Factor 1.08 |
| Profitability | Shorts Won 3/5 60% | Standard Deviation $7,088.1 |
| Average Win $1,653.34 | Best Trade (Jun 02) $56,321.62 | Sharpe Ratio -54.17 |
| Average Loss -$1,719.16 | Worst Trade (Oct 16) -$144,986.03 | Z-Score -6.42 (100%) |
| Commissions $0 | Avg. Trade Length 1m 3w 1d | Expectancy $61.55 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 43.36% | 55.76% | 64.6% | 71.71% | 77.76% | 83.08% | 87.86% | 92.22% | 96.25% |
| Consecutive Losing Trades | 88 | 79 | 71 | 62 | 53 | 44 | 35 | 26 | 18 | 9 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
CTNM Contineum Therapeutics, Inc. | 21,463.51 | $296,625.75 | $151,639.72 | - | -$144,986.03 | -48.88% | -10.57% |